Lupin Limited is a pharmaceutical company engaged in the development, manufacture and marketing of branded and generic medicines, biotechnology products and active pharmaceutical ingredients. Its portfolio covers therapeutic areas including cardiovascular care, diabetes, respiratory diseases, pediatrics, gastroenterology, anti-infectives and central nervous system treatments. The company also has interests in diagnostics and digital healthcare services and operates across India, the United States and other international markets. Founded in 1968, Lupin is headquartered in Mumbai, India.
Track the latest Lupin Limited share price along with important technical indicators in one place. This page provides a quick overview of the stock's current trend, momentum, and key price levels without switching between multiple charts.
You can check the live market price, Monthly, Weekly, Daily and Intraday trends, RSI values, Moving Averages (SMA), support & resistance levels, and the stock's 52-week high and low to better understand its overall market position.
Trend Screener automatically updates market data throughout trading hours, helping traders and investors stay informed with the latest technical analysis and trend information for 250+ NSE stocks.
This page brings together the most important technical indicators for Lupin Limited in one place. Instead of checking multiple charts, you can quickly review the stock's price action, trend, momentum, and key support and resistance levels from a single dashboard.
Whether you are an intraday trader, swing trader, or long-term investor, this page helps you quickly understand the current technical picture of Lupin before making your own investment decisions.
Disclaimer: TrendScreener.in is an educational stock analysis platform and is not a SEBI-registered Research Analyst or Investment Advisor. The information on this page is generated using technical indicators and market data and should not be considered as investment advice or buy/sell recommendations. Please do your own research before investing.